Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Cloud-Based System Monitors Vital Signs

By HospiMedica International staff writers
Posted on 26 Aug 2019
An innovative wireless device communicates with smartphones or third-party customized applications, sending raw vital signs data to the cloud for computation.

The DynoSense (San Jose, CA, USA) Vital Signs Measuring System collects a variety of input data representing a range of health metrics, including electrocardiogram (ECG) readings, respiration rate (RR), body temperature, arterial hemoglobin oxygen saturation (SpO2), perfusion index (PI), an optical photoplethysmogram (PPG) for pulse rate (PR), heart rate (HR), and heart rate variability (HRV), and others. More...
In contrast to traditional systems, the raw data is analyzed and the results computed not in the device itself, but rather in the cloud.

An intelligent analytic engine that interprets the metrics offers clinically based insights that make it easier to maintain optimal health. A Health Relationship Management Services (HRMS) platform allows healthcare specialists to aggregate and interpret the health data and information in order to create actionable, personalized individualized health care plans. In addition, using medical decision support algorithms (MDSA), healthcare companies can supply more comprehensive clinical and financial outcomes, creating a unique experience for people with high-risk health factors or chronic conditions.

In addition, DynoSense offers DynoCapture, a Software-as-a-Service (SaaS) platform that includes an innovative health scoring system, called DynaScore, which predicts clinical exacerbation days in advance of a critical event. Care providers have access to the DynoCapture dashboard, where they can monitor periodic measured status from the device, surveys, user habits and even receive alerts of unusual or troubling changes in a member's routine. Members also have the option to communicate via text and video to receive support from healthcare experts.

“We are on the path to take advantage of the shift to advanced AI based monitoring systems and digital therapeutics methods to improve health and wellness,” said Saeed Azimi, founder and CEO of DynoSense. “As a person with my own chronic health condition, I have come to understand the power of receiving informed preventive and self-empowering alerts that are coupled with my clinical care specialists.”

Related Links:
DynoSense


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Infant Incubator
OKM 801
Morcellator
TCM 3000 BL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.